| ![](/images/empty_line.GIF) |
| |
| |
![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) |
![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) |
PR:000001810 | CSF-1/PDGF receptor-type tyrosine-protein kinase | | | ![](/images/empty_line.GIF) | | |
| |
![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) |
![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) |
PR:P36888 | receptor-type tyrosine-protein kinase FLT3 (human) | | | ![](/images/empty_line.GIF) | | |
![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) |
![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) |
PR:000062985 | receptor-type tyrosine-protein kinase FLT3 sequence variant D835F, signal peptide removed form (human) | | | ![](/images/empty_line.GIF) | | |
| |
| |
![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) |
![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) |
PR:P36888 | receptor-type tyrosine-protein kinase FLT3 (human) | | | ![](/images/empty_line.GIF) | | |
![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) | ![](/images/empty_line.GIF) |
![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) ![](/images/empty_line.GIF) |
PR:000062985 | receptor-type tyrosine-protein kinase FLT3 sequence variant D835F, signal peptide removed form (human) | | | ![](/images/empty_line.GIF) | | |